XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.540
-0.035 (-1.36%)
At close: Apr 28, 2026, 4:00 PM EDT
2.545
+0.005 (0.20%)
After-hours: Apr 28, 2026, 4:10 PM EDT
XBiotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
85
Market Cap
77.44M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gossamer Bio | 48.47M |
| ImmuCell | 27.64M |
| TScan Therapeutics | 10.33M |
| Alterity Therapeutics | 4.43M |
| aTyr Pharma | 190.00K |
XBIT News
- 1 year ago - The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation - Accesswire
- 1 year ago - The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into XBiotech Inc. For Securities Fraud - Accesswire
- 1 year ago - XBiotech Inc. (XBIT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 1 year ago - Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Shareholders to Inquire about Securities Investigation - Accesswire
- 1 year ago - The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into XBiotech Inc. For Securities Fraud - Accesswire
- 1 year ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect - Accesswire
- 1 year ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out - Accesswire
- 1 year ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against XBiotech Inc. (XBIT) and Encourages Investors to Learn More About the Investigation - Accesswire